The Hospital del Mar Research Institute to Lead Three Clinical Trials Thanks to Independent Research Project Grants from the Carlos III Health Institute

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

1 year ago
NK Cells, Immunosuppression, Kidney Transplantation, Stem Cells, ALS

The latest call for independent research project grants from the Carlos III Health Institute has selected three projects led by researchers from the Hospital del Mar Research Institute. These projects...

Multidisciplinary care increases the quality of life and survival of ALS patients

by Hospital Universitari de Bellvitge

5 years ago
centralized care, ALS

he results of a study carried out by Dr. Mónica Povedano, principal investigator at IDIBELL, reinforce the value of centralized care for the disease

The role of lipids, key in the development of amyotrophic lateral sclerosis

by IRB Lleida. Institut de Recerca Biomèdica

5 years ago
ALS, amyotrophic lateral sclerosis, lipids

According to a pilot study that has analysed the spinal cords of people with ALS

Bellvitge Hospital starts a pilot test with eye readers for communication of ALS patients

by Hospital Universitari de Bellvitge

5 years ago
ALS, communication, eye readers

Eye tracking devices have established themselves as one of the most effective solutions to ensure independent and fluid communication for patients with ALS and other pathologies that affect speech art...

Voice analysis with artificial intelligence models may allow early detection of bulbar involvement in ALS

by Hospital Universitari de Bellvitge

5 years ago
ALS, early detection, Voice analysis, Technology

A study by the International Center for Numerical Methods in Engineering (CIMNE) and the University of Lleida (UdL) in which Bellvitge Hospital has participated has developed automated voice markers t...

Researchers perform thousands of mutations to understand amyotrophic lateral sclerosis

by IBEC - Institut de Bioenginyeria de Catalunya

7 years ago
amyotrophic lateral sclerosis, ALS, neurodegenerative disease, mutations

Researchers from IBEC and CRG in Barcelona use a technique called high-throughput mutagenesis to study Amyotrophic Lateral Sclerosis (ALS), with unexpected results.

Grupo Témporing supports IDIBELL's research on ELA

by IBEC - Institut de Bioenginyeria de Catalunya

10 years ago
IDIBELL, ALS, neurodegenerative diseases

IDIBELL and the Temporing Group Company, headquartered in Barcelona, have reached a sponsorship agreement to boost funding for research on amyotrophic lateral sclerosis (ALS). Temporing is one of the ...